NOT KNOWN FACTUAL STATEMENTS ABOUT OTAMIXABAN

), assists to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only when they ended up independently inhibited, lending assist to the proposal that a mixture drug therapy focusing on these motors could be a workable strategy for overcoming chemotherapeu